首页 > 最新文献

Neurochemistry international最新文献

英文 中文
Activation of the β2-adrenoceptor by formoterol induces calcium-dependent exocytosis of synaptic vesicles at the neuromuscular junction in a sex-specific manner 福莫特罗激活β2-肾上腺素受体可诱导神经肌肉连接处突触囊泡以性别特异性方式发生钙依赖性胞外分泌
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-26 DOI: 10.1016/j.neuint.2025.106040
Kivia B.S. Santos , Matheus de Castro Fonseca , Gabriel H.M. Teixeira , Bruno Sanches , Silvia Guatimosim , Leonardo Rossi , Pablo W. Verly , Elisa Santiago Pereira , Walter Cavalcante , Alexander Birbrair , Enrrico Bloise , Juan C. Tapia , Cristina Guatimosim
Increasing evidence suggests that the sympathetic nervous system profoundly interacts with skeletal muscle, influencing both muscle fiber function and composition. β2-ARs, the predominant adrenergic receptor subtype in muscle fibers, have been shown to enhance protein synthesis, reduce protein degradation, facilitate muscle contraction and relaxation, and improve neuromuscular junction (NMJ) transmission upon activation. In this study, we investigated the effects of Formoterol, a highly selective β2-adrenoceptors (β2-AR) agonist, on the presynaptic terminal of motor neurons. We used myography, FM1-43 fluorescent dye assays, and transmission electron microscopy (TEM) to evaluate the NMJ following β2-AR activation. We demonstrated that β2-AR activation by Formoterol enhances muscle contractility and both spontaneous and evoked exocytosis of acetylcholine (ACh)-containing synaptic vesicles at the mouse diaphragm NMJ. Formoterol-induced morphological changes in diaphragmatic NMJs were consistent with increased exo-endocytic activity. Notably, Formoterol-evoked exocytosis displayed sexual dimorphism, with females showing a significantly milder response compared to males. In females, Formoterol-induced synaptic vesicles exocytosis was mediated solely by P/Q-type voltage-activated Ca2+ channels, whereas in males, it involved both P/Q-type channels, transient receptor potential channel of the vanilloid subtype (TRPV) 1 calcium channels, and an additional, yet unidentified, component. Orchiectomized males exhibited responses to Formoterol similar to the females, whereas ovariectomy did not modify female drug responses, indicating that male hormonal environment orchestrates the sex-differences herein described. These findings not only highlight the importance of sex-specific mechanisms but also reveal a novel effect of β2-AR activation directly on presynaptic terminals by Formoterol, enhancing exocytosis at the NMJ and thereby increasing neuromuscular transmission.
越来越多的证据表明,交感神经系统深刻地与骨骼肌相互作用,影响肌纤维的功能和组成。β2-ARs是肌纤维中主要的肾上腺素能受体亚型,已被证明可增强蛋白质合成,减少蛋白质降解,促进肌肉收缩和松弛,并在激活时改善神经肌肉连接(NMJ)的传递。本研究研究了高选择性β2-肾上腺素受体(β2-AR)激动剂福莫特罗(Formoterol)对运动神经元突触前末端的影响。我们使用肌图、FM1-43荧光染料测定和透射电子显微镜(TEM)来评估β2-AR激活后的NMJ。我们证明了福莫特罗激活β2-AR增强了小鼠膈肌NMJ中含有乙酰胆碱(ACh)的突触囊泡的自发和诱发的肌肉收缩性和胞外分泌。福莫特罗诱导的膈肌NMJs形态学改变与外吞活性增加一致。值得注意的是,福莫特罗诱发的胞吐表现出性别二态性,雌性的反应明显比雄性温和。在雌性中,福摩特罗诱导的突触囊泡胞外分泌仅由P/ q型电压激活的Ca2+通道介导,而在雄性中,它涉及P/ q型通道,瞬时受体电位通道的香草酸亚型(TRPV) 1钙通道,以及一个额外的,尚未确定的成分。切除卵巢的雄鼠对福莫特罗的反应与雌鼠相似,而卵巢切除并没有改变雌鼠对福莫特罗的反应,这表明雄性激素环境协调了本文所述的性别差异。这些发现不仅强调了性别特异性机制的重要性,而且揭示了Formoterol直接激活β2-AR对突触前末端的新作用,增强NMJ的胞吐,从而增加神经肌肉传递。
{"title":"Activation of the β2-adrenoceptor by formoterol induces calcium-dependent exocytosis of synaptic vesicles at the neuromuscular junction in a sex-specific manner","authors":"Kivia B.S. Santos ,&nbsp;Matheus de Castro Fonseca ,&nbsp;Gabriel H.M. Teixeira ,&nbsp;Bruno Sanches ,&nbsp;Silvia Guatimosim ,&nbsp;Leonardo Rossi ,&nbsp;Pablo W. Verly ,&nbsp;Elisa Santiago Pereira ,&nbsp;Walter Cavalcante ,&nbsp;Alexander Birbrair ,&nbsp;Enrrico Bloise ,&nbsp;Juan C. Tapia ,&nbsp;Cristina Guatimosim","doi":"10.1016/j.neuint.2025.106040","DOIUrl":"10.1016/j.neuint.2025.106040","url":null,"abstract":"<div><div>Increasing evidence suggests that the sympathetic nervous system profoundly interacts with skeletal muscle, influencing both muscle fiber function and composition. β<sub>2</sub>-ARs, the predominant adrenergic receptor subtype in muscle fibers, have been shown to enhance protein synthesis, reduce protein degradation, facilitate muscle contraction and relaxation, and improve neuromuscular junction (NMJ) transmission upon activation. In this study, we investigated the effects of Formoterol, a highly selective β<sub>2</sub>-adrenoceptors (β<sub>2</sub>-AR) agonist, on the presynaptic terminal of motor neurons. We used myography, FM1-43 fluorescent dye assays, and transmission electron microscopy (TEM) to evaluate the NMJ following β<sub>2</sub>-AR activation. We demonstrated that β<sub>2</sub>-AR activation by Formoterol enhances muscle contractility and both spontaneous and evoked exocytosis of acetylcholine (ACh)-containing synaptic vesicles at the mouse diaphragm NMJ. Formoterol-induced morphological changes in diaphragmatic NMJs were consistent with increased exo-endocytic activity. Notably, Formoterol-evoked exocytosis displayed sexual dimorphism, with females showing a significantly milder response compared to males. In females, Formoterol-induced synaptic vesicles exocytosis was mediated solely by P/Q-type voltage-activated Ca<sup>2+</sup> channels, whereas in males, it involved both P/Q-type channels, transient receptor potential channel of the vanilloid subtype (TRPV) 1 calcium channels, and an additional, yet unidentified, component. Orchiectomized males exhibited responses to Formoterol similar to the females, whereas ovariectomy did not modify female drug responses, indicating that male hormonal environment orchestrates the sex-differences herein described. These findings not only highlight the importance of sex-specific mechanisms but also reveal a novel effect of β<sub>2</sub>-AR activation directly on presynaptic terminals by Formoterol, enhancing exocytosis at the NMJ and thereby increasing neuromuscular transmission.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"190 ","pages":"Article 106040"},"PeriodicalIF":4.0,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144919857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting ferroptosis by electroacupuncture offers a therapeutic regimen for brain injury after ischemic stroke 电针靶向铁下垂为缺血性脑卒中后脑损伤提供了一种治疗方案
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-22 DOI: 10.1016/j.neuint.2025.106038
Wenjing Li, Qiang Li
Ischemic stroke (IS), the most prevalent form of stroke, remains a significant healthcare challenge and imposes a considerable burden on affected individuals. Ferroptosis, a form of regulated cell death (RCD) characterized by iron overload -induced lipid peroxidation, was identified as a contributor to induce cell death following brain injury after ischemic stroke. Targeting ferroptosis is a novel therapy regimen for IS. And seeking novel therapy is unmet need for IS. Electroacupuncture (EA) has been revealed to have neuroprotective effect against IS and recommended to treat IS by World Health Organization (WHO) for years, but the specific mechanism underlying EA-mediated neuroprotection is still elusive. Emerging evidences have shown that EA alleviates brain injury after ischemic stroke by inhibiting ferroptosis; however, the mechanism by which EA suppresses ferroptosis against IS has not been sufficiently clarified. In this review, we first summarizes the core molecular mechanism of ferroptosis, with an focus on interpret how ferroptosis leads to the genesis of brain injury after ischemic stroke and the novel regulation of ferroptosis during the brain injury after ischemic stroke. We then highlights our emphasize on the emerging evidences that have revealed EA inhibit ferroptosis and review their pharmacological mechanisms against brain injury after ischemic stroke. This review highlights EA as a novel therapeutic regimen for ischemic stroke by suppressing ferroptosis, synthesizing mechanistic insights into iron-dependent lipid peroxidation pathways, evaluating emerging experimental evidence of EA's neuroprotection, and proposing targeted clinical strategies to mitigate post-stroke brain injury.
缺血性中风(IS)是最常见的中风形式,仍然是一个重大的医疗挑战,并对受影响的个人施加了相当大的负担。铁凋亡是一种以铁超载诱导的脂质过氧化为特征的调节细胞死亡(RCD)形式,被认为是缺血性卒中后脑损伤诱导细胞死亡的一个因素。靶向铁下垂是一种新的is治疗方案。而寻求新的治疗方法是is尚未满足的需求。电针(EA)对IS具有神经保护作用,多年来一直被世界卫生组织(WHO)推荐用于治疗IS,但电针介导的神经保护的具体机制尚不清楚。新证据表明,EA可通过抑制铁下垂减轻缺血性脑卒中后脑损伤;然而,EA抑制铁下垂对抗IS的机制尚未得到充分阐明。本文首先综述了铁下垂的核心分子机制,重点阐述了铁下垂如何导致缺血性脑卒中后脑损伤的发生,以及铁下垂在缺血性脑卒中后脑损伤中的新调控。然后,我们强调了我们的重点新证据表明,EA抑制铁下垂和回顾其对缺血性脑卒中后脑损伤的药理学机制。这篇综述强调了EA作为缺血性卒中的一种新的治疗方案,通过抑制铁下沉,合成铁依赖性脂质过氧化途径的机制见解,评估EA神经保护的新实验证据,并提出有针对性的临床策略来减轻脑卒中后脑损伤。
{"title":"Targeting ferroptosis by electroacupuncture offers a therapeutic regimen for brain injury after ischemic stroke","authors":"Wenjing Li,&nbsp;Qiang Li","doi":"10.1016/j.neuint.2025.106038","DOIUrl":"10.1016/j.neuint.2025.106038","url":null,"abstract":"<div><div>Ischemic stroke (IS), the most prevalent form of stroke, remains a significant healthcare challenge and imposes a considerable burden on affected individuals. Ferroptosis, a form of regulated cell death (RCD) characterized by iron overload -induced lipid peroxidation, was identified as a contributor to induce cell death following brain injury after ischemic stroke. Targeting ferroptosis is a novel therapy regimen for IS. And seeking novel therapy is unmet need for IS. Electroacupuncture (EA) has been revealed to have neuroprotective effect against IS and recommended to treat IS by World Health Organization (WHO) for years, but the specific mechanism underlying EA-mediated neuroprotection is still elusive. Emerging evidences have shown that EA alleviates brain injury after ischemic stroke by inhibiting ferroptosis; however, the mechanism by which EA suppresses ferroptosis against IS has not been sufficiently clarified. In this review, we first summarizes the core molecular mechanism of ferroptosis, with an focus on interpret how ferroptosis leads to the genesis of brain injury after ischemic stroke and the novel regulation of ferroptosis during the brain injury after ischemic stroke. We then highlights our emphasize on the emerging evidences that have revealed EA inhibit ferroptosis and review their pharmacological mechanisms against brain injury after ischemic stroke. This review highlights EA as a novel therapeutic regimen for ischemic stroke by suppressing ferroptosis, synthesizing mechanistic insights into iron-dependent lipid peroxidation pathways, evaluating emerging experimental evidence of EA's neuroprotection, and proposing targeted clinical strategies to mitigate post-stroke brain injury.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"190 ","pages":"Article 106038"},"PeriodicalIF":4.0,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144896185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms 神经退行性疾病的表转录组失调及其对疾病病理和机制的影响
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-20 DOI: 10.1016/j.neuint.2025.106037
Andrew M. Shafik, Peng Jin
RNA modifications, collectively referred to as the epitranscriptome, play a crucial role in regulating RNA metabolism, influencing key processes such as splicing, stability, localization, and translation. Increasing evidence now links dysregulation of the epitranscriptome to neurodegenerative diseases. In this review, we focus on four RNA modifications and their influence on neurodegenerative pathways, including synaptic function, neuroinflammatory signaling, and stress granule formation. These findings highlight the complex and multifaceted roles that RNA modifications play in neurodegeneration, emphasizing their emerging potential as biomarkers and therapeutic targets.
RNA修饰,统称为表转录组,在调节RNA代谢中起着至关重要的作用,影响着剪接、稳定性、定位和翻译等关键过程。现在越来越多的证据表明,表转录组失调与神经退行性疾病有关。在这篇综述中,我们重点介绍了四种RNA修饰及其对神经退行性通路的影响,包括突触功能、神经炎症信号和应激颗粒的形成。这些发现强调了RNA修饰在神经变性中发挥的复杂和多方面的作用,强调了它们作为生物标志物和治疗靶点的新兴潜力。
{"title":"Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms","authors":"Andrew M. Shafik,&nbsp;Peng Jin","doi":"10.1016/j.neuint.2025.106037","DOIUrl":"10.1016/j.neuint.2025.106037","url":null,"abstract":"<div><div>RNA modifications, collectively referred to as the epitranscriptome, play a crucial role in regulating RNA metabolism, influencing key processes such as splicing, stability, localization, and translation. Increasing evidence now links dysregulation of the epitranscriptome to neurodegenerative diseases. In this review, we focus on four RNA modifications and their influence on neurodegenerative pathways, including synaptic function, neuroinflammatory signaling, and stress granule formation. These findings highlight the complex and multifaceted roles that RNA modifications play in neurodegeneration, emphasizing their emerging potential as biomarkers and therapeutic targets.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"190 ","pages":"Article 106037"},"PeriodicalIF":4.0,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144896186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opioids induce constipation by prompting alpha-Synuclein hyperphosphorylation in the colonic myenteric plexus 阿片类药物通过促进结肠肌丛α -突触核蛋白过度磷酸化诱导便秘
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-18 DOI: 10.1016/j.neuint.2025.106036
Binghan Jia , Yuqiong Zhao , Xiaojie Ren , Dandan Zhang , Hua Jia , Dengke Wang , Lixin Wang , Junping Li
Opioid-induced constipation (OIC) is the most common gastrointestinal disorder associated with opioid use. It is linked to impaired neurotransmitter release. Alpha-Synuclein (α-Syn) plays a crucial role in maintaining neurotransmitter homeostasis and regulating synaptic plasticity in the nervous system. However, its role in the disease progression remains unclear. In the present study, we investigated the impact of α-Syn hyperphosphorylation on colonic dysmotility and constipation symptoms using a Sprague-Dawley rat model of OIC. Our results suggest that α-Syn expression at the Ser129 phosphorylation site (pS129-α-Syn) is significantly increased in the colonic myenteric layer of OIC rats. Conversely, inhibiting pS129-α-Syn reversed the colonic dysmotility and increased the expression of synaptic functional proteins, such as Synapsin-1, Synaptotagmin-1, vesicle-associated membrane protein 2 (VAMP-2), and Syntaxin-1, as well as enteric neurotransmitter synthases, including neuronal nitric oxide synthase (nNOS) and adenosine triphosphate synthase (ATPB). Additionally, we found that opioids downregulate GSK3β protein expression at the Ser9 site by activating the μ-opioid receptors (MOR). This increases GSK3β kinase activity, ultimately inducing pS129-α-Syn overexpression. In summary, the development of OIC correlates with α-Syn hyperphosphorylation in myenteric plexus neurons in the colon. Opioids can inhibit synaptic vesicle trafficking and enteric neurotransmitter release via the GSK3β/α-Syn hyperphosphorylation signaling axis, ultimately leading to colonic dysmotility and constipation.
阿片类药物引起的便秘(OIC)是与阿片类药物使用相关的最常见的胃肠道疾病。它与神经递质释放受损有关。α-突触核蛋白(α-Syn)在神经系统中维持神经递质稳态和调节突触可塑性方面起着至关重要的作用。然而,它在疾病进展中的作用仍不清楚。本研究采用Sprague-Dawley大鼠OIC模型,研究α-Syn过磷酸化对结肠运动障碍和便秘症状的影响。我们的结果表明,Ser129磷酸化位点(pS129-α-Syn)的α-Syn在OIC大鼠结肠肌肠层的表达显著增加。相反,抑制pS129-α-Syn逆转结肠运动障碍,增加突触功能蛋白Synapsin-1、Synaptotagmin-1、囊泡相关膜蛋白2 (VAMP-2)和Syntaxin-1的表达,以及肠内神经递质合成酶,包括神经元一氧化氮合成酶(nNOS)和三磷酸腺苷合成酶(ATPB)的表达。此外,我们发现阿片通过激活μ-阿片受体(MOR)下调Ser9位点GSK3β蛋白的表达。这增加了GSK3β激酶活性,最终诱导pS129-α-Syn过表达。综上所述,OIC的发生与结肠肌丛神经元α-Syn过磷酸化有关。阿片类药物可通过GSK3β/α-Syn过磷酸化信号轴抑制突触囊泡运输和肠内神经递质释放,最终导致结肠运动障碍和便秘。
{"title":"Opioids induce constipation by prompting alpha-Synuclein hyperphosphorylation in the colonic myenteric plexus","authors":"Binghan Jia ,&nbsp;Yuqiong Zhao ,&nbsp;Xiaojie Ren ,&nbsp;Dandan Zhang ,&nbsp;Hua Jia ,&nbsp;Dengke Wang ,&nbsp;Lixin Wang ,&nbsp;Junping Li","doi":"10.1016/j.neuint.2025.106036","DOIUrl":"10.1016/j.neuint.2025.106036","url":null,"abstract":"<div><div>Opioid-induced constipation (OIC) is the most common gastrointestinal disorder associated with opioid use. It is linked to impaired neurotransmitter release. Alpha-Synuclein (α-Syn) plays a crucial role in maintaining neurotransmitter homeostasis and regulating synaptic plasticity in the nervous system. However, its role in the disease progression remains unclear. In the present study, we investigated the impact of α-Syn hyperphosphorylation on colonic dysmotility and constipation symptoms using a Sprague-Dawley rat model of OIC. Our results suggest that α-Syn expression at the Ser129 phosphorylation site (pS129-α-Syn) is significantly increased in the colonic myenteric layer of OIC rats. Conversely, inhibiting pS129-α-Syn reversed the colonic dysmotility and increased the expression of synaptic functional proteins, such as Synapsin-1, Synaptotagmin-1, vesicle-associated membrane protein 2 (VAMP-2), and Syntaxin-1, as well as enteric neurotransmitter synthases, including neuronal nitric oxide synthase (nNOS) and adenosine triphosphate synthase (ATPB). Additionally, we found that opioids downregulate GSK3β protein expression at the Ser9 site by activating the μ-opioid receptors (MOR). This increases GSK3β kinase activity, ultimately inducing pS129-α-Syn overexpression. In summary, the development of OIC correlates with α-Syn hyperphosphorylation in myenteric plexus neurons in the colon. Opioids can inhibit synaptic vesicle trafficking and enteric neurotransmitter release via the GSK3β/α-Syn hyperphosphorylation signaling axis, ultimately leading to colonic dysmotility and constipation.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"190 ","pages":"Article 106036"},"PeriodicalIF":4.0,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144889131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating metabolomic changes in Lennox-Gastaut syndrome: correlation with clinico-radiological severity lenox - gastaut综合征的循环代谢组学改变:与临床放射学严重程度的相关性
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-12 DOI: 10.1016/j.neuint.2025.106032
Jayantee Kalita , Aditi Pandey , Firoz M. Nizami , Ashish K. Dubey , Bikash Baishya
Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy characterized by multiple types of seizures typically occurring between 1 and 7 years of age, cognitive impairment and characteristic electroencephalographic abnormalities. Circulating metabolomic profile may give insight into the ongoing metabolic pathway abnormalities in these patients, but there is no such study. We report NMR based metabolomic profile in LGS and its association with clinical severity, MRI changes and EEG findings. LGS children between 2 and 18 years were included based on clinical and EEG diagnostic criteria. Detailed neurological examinations, frequency and type of seizures, EEG changes, cranial MRI and NMR based serum metabolomic profile were measured. The Clinical Global Impairment Severity Scale (CGI-S) was used to rate severity of LGS. Twenty-six LGS patients and 11 healthy matched controls were included. The median age of the patients was 6 (range 2–17) years, and 19 were males. Their median CGI-S score was 6, and all had more than one type of seizures. Seven metabolites namely lactate, glucose, glutamate, pyruvate, glutamine, glycine, citrate and creatinine were crucial for discrimination of LGS from the controls, among which glutamate was upregulated and citrate, pyruvate, and glutamine were down regulated in LGS. Glutamate associated with developmental quotient (r = −0.48) and pyruvate with focal seizures (r = 0.47) and cystic encephalomalacia on cranial MRI (p = 0.02). NMR metabolomic profile including glutamate, glutamine, glycine, glucose, pyruvate, lactate, citrate and creatinine can discriminate LGS from the controls. Role of antiglutamatergic drugs may be beneficial in controlling seizures, and needs future study.
lenox - gastaut综合征(LGS)是一种癫痫性脑病,其特征是多种类型的癫痫发作,通常发生在1至7岁之间,伴有认知障碍和特征性脑电图异常。循环代谢组学分析可能有助于了解这些患者持续的代谢途径异常,但目前还没有这样的研究。我们报告了基于核磁共振的LGS代谢组学特征及其与临床严重程度、核磁共振变化和脑电图结果的关联。根据临床和脑电图诊断标准纳入2-18岁的LGS儿童。测量详细的神经学检查、癫痫发作的频率和类型、脑电图变化、颅脑MRI和基于核磁共振的血清代谢组学特征。采用临床整体损害严重程度量表(CGI-S)评定LGS的严重程度。纳入26例LGS患者和11例健康匹配对照。患者的中位年龄为6岁(范围2-17岁),男性19例。他们的CGI-S评分中位数为6分,并且都有不止一种类型的癫痫发作。乳酸、葡萄糖、谷氨酸、丙酮酸、谷氨酰胺、甘氨酸、柠檬酸和肌酐是LGS与对照组区分的关键代谢物,其中谷氨酸上调,柠檬酸、丙酮酸和谷氨酰胺下调。谷氨酸与发育商相关(r = -0.48),丙酮酸与局灶性癫痫发作相关(r = 0.47),头颅MRI显示的囊性脑软化相关(p = 0.02)。核磁共振代谢组谱包括谷氨酸、谷氨酰胺、甘氨酸、葡萄糖、丙酮酸、乳酸、柠檬酸和肌酐,可以将LGS与对照组区分开来。抗谷氨酸能药物的作用可能有利于控制癫痫发作,有待进一步研究。
{"title":"Circulating metabolomic changes in Lennox-Gastaut syndrome: correlation with clinico-radiological severity","authors":"Jayantee Kalita ,&nbsp;Aditi Pandey ,&nbsp;Firoz M. Nizami ,&nbsp;Ashish K. Dubey ,&nbsp;Bikash Baishya","doi":"10.1016/j.neuint.2025.106032","DOIUrl":"10.1016/j.neuint.2025.106032","url":null,"abstract":"<div><div>Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy characterized by multiple types of seizures typically occurring between 1 and 7 years of age, cognitive impairment and characteristic electroencephalographic abnormalities. Circulating metabolomic profile may give insight into the ongoing metabolic pathway abnormalities in these patients, but there is no such study. We report NMR based metabolomic profile in LGS and its association with clinical severity, MRI changes and EEG findings. LGS children between 2 and 18 years were included based on clinical and EEG diagnostic criteria. Detailed neurological examinations, frequency and type of seizures, EEG changes, cranial MRI and NMR based serum metabolomic profile were measured. The Clinical Global Impairment Severity Scale (CGI-S) was used to rate severity of LGS. Twenty-six LGS patients and 11 healthy matched controls were included. The median age of the patients was 6 (range 2–17) years, and 19 were males. Their median CGI-S score was 6, and all had more than one type of seizures. Seven metabolites namely lactate, glucose, glutamate, pyruvate, glutamine, glycine, citrate and creatinine were crucial for discrimination of LGS from the controls, among which glutamate was upregulated and citrate, pyruvate, and glutamine were down regulated in LGS. Glutamate associated with developmental quotient (r = −0.48) and pyruvate with focal seizures (r = 0.47) and cystic encephalomalacia on cranial MRI (p = 0.02). NMR metabolomic profile including glutamate, glutamine, glycine, glucose, pyruvate, lactate, citrate and creatinine can discriminate LGS from the controls. Role of antiglutamatergic drugs may be beneficial in controlling seizures, and needs future study.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"189 ","pages":"Article 106032"},"PeriodicalIF":4.0,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined supplementation of short-chain fatty acids reduces hyperphosphorylation of Tau at T181,T231 and S396 sites and improves cognitive impairment in a chemically induced AD mouse model via regulation of HDAC and Keap1 联合补充短链脂肪酸可以减少Tau在T181、T231和S396位点的过度磷酸化,并通过调节HDAC和Keap1改善化学诱导AD小鼠模型的认知障碍
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-12 DOI: 10.1016/j.neuint.2025.106034
Dan Pu , Ye Jin , Longxing Wang , Renjun Wang , Lingyu Li , Yang Song , Xiaofei Han
Alzheimer's disease (AD) is characterized by the pathological hallmarks of β-amyloid deposition and Tau protein hyperphosphorylation, with memory loss and cognitive dysfunction as its primary clinical manifestations. The incidence of AD has been progressively increasing in recent years. Short-chain fatty acids (SCFAs), key effector molecules in host-gut microbial interactions, play a crucial role in maintaining central nervous system homeostasis. In this study, AD mouse model was established via AlCl3/D-gal induction. The effects of mixed SCFA intervention on spatial learning and memory in AD model mice were assessed using behavioral tests, including the Morris Water Maze. Levels of pro-inflammatory cytokines and activities of oxidative stress-related enzymes in brain and colon tissues were quantified using ELISA and commercial kits. Key protein expression levels were analyzed by Western blot, immunohistochemistry, and immunofluorescence. Results demonstrated that SCFAs significantly alleviated cognitive dysfunction in AD model, reduced Tau hyperphosphorylation at T181, T231 and S396 sites, suppressed pro-inflammatory cytokine release, and enhanced antioxidant capacity, but with no reversal in elevated Aβ levels in AD model. Mechanistically, SCFAs inhibited glial cell activation, upregulated MCT-1 and tight junction proteins in the blood-brain barrier and strengthened gut-brain barrier integrity, potentially regulating small molecule trans-barrier transport. Furthermore, examination of relevant protein expressions revealed that SCFAs activated HDAC1 and inhibited overexpressed HDAC3 and Keap-1 in AD mice model. These findings suggest that SCFAs may regulate epigenetic modifications in the brain of AD to exert neuroprotective effects. This study provides novel evidence supporting the potential of symbiotic microbe-derived SCFAs in alleviating AD.
阿尔茨海默病(Alzheimer's disease, AD)以β-淀粉样蛋白沉积和Tau蛋白过度磷酸化为病理特征,以记忆丧失和认知功能障碍为主要临床表现。近年来,阿尔茨海默病的发病率逐渐增加。短链脂肪酸(SCFAs)是宿主-肠道微生物相互作用的关键效应分子,在维持中枢神经系统稳态中起着至关重要的作用。本研究采用AlCl3/D-gal诱导法建立AD小鼠模型。采用Morris水迷宫等行为学测试评估混合SCFA干预对AD模型小鼠空间学习记忆的影响。采用酶联免疫吸附试验(ELISA)和商用试剂盒定量测定脑和结肠组织中促炎细胞因子水平和氧化应激相关酶活性。Western blot、免疫组织化学和免疫荧光分析关键蛋白的表达水平。结果表明,SCFAs可显著缓解AD模型的认知功能障碍,降低T181、T231和S396位点的Tau过度磷酸化,抑制促炎细胞因子释放,增强抗氧化能力,但对AD模型中升高的Aβ水平无逆转作用。从机制上讲,SCFAs抑制胶质细胞活化,上调血脑屏障中的MCT-1和紧密连接蛋白,增强肠脑屏障完整性,可能调节小分子跨屏障运输。此外,检测相关蛋白表达发现,SCFAs在AD小鼠模型中激活HDAC1,抑制HDAC3和Keap-1过表达。这些发现表明,SCFAs可能调节阿尔茨海默病大脑的表观遗传修饰,发挥神经保护作用。这项研究提供了新的证据,支持共生微生物来源的scfa在缓解AD方面的潜力。
{"title":"Combined supplementation of short-chain fatty acids reduces hyperphosphorylation of Tau at T181,T231 and S396 sites and improves cognitive impairment in a chemically induced AD mouse model via regulation of HDAC and Keap1","authors":"Dan Pu ,&nbsp;Ye Jin ,&nbsp;Longxing Wang ,&nbsp;Renjun Wang ,&nbsp;Lingyu Li ,&nbsp;Yang Song ,&nbsp;Xiaofei Han","doi":"10.1016/j.neuint.2025.106034","DOIUrl":"10.1016/j.neuint.2025.106034","url":null,"abstract":"<div><div>Alzheimer's disease (AD) is characterized by the pathological hallmarks of β-amyloid deposition and Tau protein hyperphosphorylation, with memory loss and cognitive dysfunction as its primary clinical manifestations. The incidence of AD has been progressively increasing in recent years. Short-chain fatty acids (SCFAs), key effector molecules in host-gut microbial interactions, play a crucial role in maintaining central nervous system homeostasis. In this study, AD mouse model was established via AlCl<sub>3</sub>/D-gal induction. The effects of mixed SCFA intervention on spatial learning and memory in AD model mice were assessed using behavioral tests, including the Morris Water Maze. Levels of pro-inflammatory cytokines and activities of oxidative stress-related enzymes in brain and colon tissues were quantified using ELISA and commercial kits. Key protein expression levels were analyzed by Western blot, immunohistochemistry, and immunofluorescence. Results demonstrated that SCFAs significantly alleviated cognitive dysfunction in AD model, reduced Tau hyperphosphorylation at T181, T231 and S396 sites, suppressed pro-inflammatory cytokine release, and enhanced antioxidant capacity, but with no reversal in elevated Aβ levels in AD model. Mechanistically, SCFAs inhibited glial cell activation, upregulated MCT-1 and tight junction proteins in the blood-brain barrier and strengthened gut-brain barrier integrity, potentially regulating small molecule <em>trans</em>-barrier transport. Furthermore, examination of relevant protein expressions revealed that SCFAs activated HDAC1 and inhibited overexpressed HDAC3 and Keap-1 in AD mice model. These findings suggest that SCFAs may regulate epigenetic modifications in the brain of AD to exert neuroprotective effects. This study provides novel evidence supporting the potential of symbiotic microbe-derived SCFAs in alleviating AD.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"189 ","pages":"Article 106034"},"PeriodicalIF":4.0,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144852112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epigenetic dysregulation and the etiology of spina bifida 表观遗传失调和脊柱裂的病因学。
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-11 DOI: 10.1016/j.neuint.2025.106033
Tabitha Lumour-Mensah , Susan Korrick , Bernardo Lemos , Maitreyi Mazumdar
Spina bifida is a complex and multifactorial congenital defect driven by both genetic and environmental factors. As such, epigenetic studies of spina bifida present an opportunity to study the joint contribution of both genes and the environment in the development of this disorder. This review focuses specifically on epigenetic research that may help us to understand the ways in which dysregulation of the epigenome and downstream cellular processes can confer increased risk of spina bifida. To do so, we discuss the epigenetic regulation of genes linked to spina bifida risk among children born with the disorder and their parents as well as evidence from experimental studies. We also discuss pathways necessary for normal neural tube development and specific documented dysregulation of these pathways in individuals with spina bifida. We conclude that the epigenome plays an important role in spina bifida etiology and should be further studied in additional populations, and tissue types, as well as cellular and animal models.
脊柱裂是一种复杂的多因素先天性缺陷,由遗传和环境因素共同驱动。因此,脊柱裂的表观遗传学研究提供了一个机会来研究基因和环境在这种疾病发展中的共同作用。这篇综述特别关注表观遗传学研究,这可能有助于我们理解表观基因组和下游细胞过程失调如何增加脊柱裂的风险。为此,我们讨论了与脊柱裂风险相关的基因的表观遗传调控,这些基因与先天性脊柱裂的儿童及其父母有关。我们还讨论了正常神经管发育所必需的途径,以及脊柱裂患者这些途径的特殊记录失调。我们得出结论,表观基因组在脊柱裂的病因学中起着重要作用,应该在更多的人群、组织类型以及细胞和动物模型中进一步研究。
{"title":"Epigenetic dysregulation and the etiology of spina bifida","authors":"Tabitha Lumour-Mensah ,&nbsp;Susan Korrick ,&nbsp;Bernardo Lemos ,&nbsp;Maitreyi Mazumdar","doi":"10.1016/j.neuint.2025.106033","DOIUrl":"10.1016/j.neuint.2025.106033","url":null,"abstract":"<div><div>Spina bifida is a complex and multifactorial congenital defect driven by both genetic and environmental factors. As such, epigenetic studies of spina bifida present an opportunity to study the joint contribution of both genes and the environment in the development of this disorder. This review focuses specifically on epigenetic research that may help us to understand the ways in which dysregulation of the epigenome and downstream cellular processes can confer increased risk of spina bifida. To do so, we discuss the epigenetic regulation of genes linked to spina bifida risk among children born with the disorder and their parents as well as evidence from experimental studies. We also discuss pathways necessary for normal neural tube development and specific documented dysregulation of these pathways in individuals with spina bifida. We conclude that the epigenome plays an important role in spina bifida etiology and should be further studied in additional populations, and tissue types, as well as cellular and animal models.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"189 ","pages":"Article 106033"},"PeriodicalIF":4.0,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144843983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRPM8 modulation alters uptake of Transferrin-mediated Fe3+, mitochondrial Fe2+ and intracellular Ca2+-levels in microglia TRPM8调节改变小胶质细胞中铁蛋白介导的Fe3+、线粒体Fe2+和细胞内Ca2+水平的摄取。
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-08 DOI: 10.1016/j.neuint.2025.106031
Raima Sing , Deep Shikha , Chandan Goswami
Microglia play an important role in the immunity of the central nervous system, crucial in maintaining homeostasis. However, under diseased conditions, this cell accumulates Fe2+/3+, triggering inflammatory and neurotoxic effects that contribute to neurodegenerative disorders such as Alzheimer's and Parkinson's. Hence, the study of dysregulated microglial activation and overload of Fe2+/3+ is crucial in the context of neurodegenerative conditions. Emerging research has identified cold-sensitive ion channels, i.e., TRPM8 in microglia, which can regulate key subcellular functions. This study explores the regulatory function of the TRPM8 in Fe2+/3+ metabolism and its implications for potential ferroptosis in BV2 microglial cells. We used highly specific fluorescence probes, pharmacological modulators of TRPM8 and performed life cell imaging to understand the uptake of Transferrin-488, mitochondrial Fe2+-level, cellular Ca2+-levels in live BV2 cells under different experimental conditions. Our findings reveal that TRPM8 activation leads to enhanced Transferrin-488-mediated cytosolic Fe3+-uptake, disrupts mitochondrial superoxide levels, and promotes cell death. Interestingly, under inflammatory conditions induced by LPS treatment, TRPM8 exhibits a distinct functional role. These results position TRPM8 as an important regulator of microglial Fe2+/3+ metabolism. This study indicates the involvement of TRPM8 in overload of Fe2+/3+ leading to ferroptosis and potential for M1-M2 polarization in microglia. These findings impose TRPM8 as a potential therapeutic target for neurodegenerative diseases, and aging.
小胶质细胞在中枢神经系统的免疫中起着重要作用,对维持体内平衡至关重要。然而,在患病状态下,该细胞积累Fe2+/3+,引发炎症和神经毒性作用,导致神经退行性疾病,如阿尔茨海默氏症和帕金森病。因此,在神经退行性疾病的背景下,研究小胶质细胞激活失调和Fe2+/3+过载是至关重要的。新兴研究已经发现了冷敏感离子通道,即小胶质细胞中的TRPM8,它可以调节关键的亚细胞功能。本研究探讨了TRPM8在BV2小胶质细胞中对铁2+/3+代谢的调节功能及其对潜在铁凋亡的影响。我们使用高特异性荧光探针、TRPM8药理调节剂和生命细胞成像来了解不同实验条件下BV2活细胞对转铁蛋白488的摄取、线粒体Fe2+水平、细胞Ca2+水平。我们的研究结果表明,TRPM8激活导致转铁蛋白488介导的胞质Fe3+摄取增强,破坏线粒体超氧化物水平,促进细胞死亡。有趣的是,在LPS诱导的炎症条件下,TRPM8表现出明显的功能作用。这些结果表明TRPM8是小胶质细胞Fe2+/3+代谢的重要调节因子。本研究表明,TRPM8参与了Fe2+/3+过载导致铁下垂和小胶质细胞M1-M2极化的可能性。这些发现表明TRPM8是神经退行性疾病和衰老的潜在治疗靶点。
{"title":"TRPM8 modulation alters uptake of Transferrin-mediated Fe3+, mitochondrial Fe2+ and intracellular Ca2+-levels in microglia","authors":"Raima Sing ,&nbsp;Deep Shikha ,&nbsp;Chandan Goswami","doi":"10.1016/j.neuint.2025.106031","DOIUrl":"10.1016/j.neuint.2025.106031","url":null,"abstract":"<div><div>Microglia play an important role in the immunity of the central nervous system, crucial in maintaining homeostasis. However, under diseased conditions, this cell accumulates Fe<sup>2+/3+</sup>, triggering inflammatory and neurotoxic effects that contribute to neurodegenerative disorders such as Alzheimer's and Parkinson's. Hence, the study of dysregulated microglial activation and overload of Fe<sup>2+/3+</sup> is crucial in the context of neurodegenerative conditions. Emerging research has identified cold-sensitive ion channels, i.e., TRPM8 in microglia, which can regulate key subcellular functions. This study explores the regulatory function of the TRPM8 in Fe<sup>2+/3+</sup> metabolism and its implications for potential ferroptosis in BV2 microglial cells. We used highly specific fluorescence probes, pharmacological modulators of TRPM8 and performed life cell imaging to understand the uptake of Transferrin-488, mitochondrial Fe<sup>2+</sup>-level, cellular Ca<sup>2+</sup>-levels in live BV2 cells under different experimental conditions. Our findings reveal that TRPM8 activation leads to enhanced Transferrin-488-mediated cytosolic Fe<sup>3+</sup>-uptake, disrupts mitochondrial superoxide levels, and promotes cell death. Interestingly, under inflammatory conditions induced by LPS treatment, TRPM8 exhibits a distinct functional role. These results position TRPM8 as an important regulator of microglial Fe<sup>2+/3+</sup> metabolism. This study indicates the involvement of TRPM8 in overload of Fe<sup>2+/3+</sup> leading to ferroptosis and potential for M1-M2 polarization in microglia. These findings impose TRPM8 as a potential therapeutic target for neurodegenerative diseases, and aging.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"189 ","pages":"Article 106031"},"PeriodicalIF":4.0,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased spinal adenosine after subacute cervical injury correlates with sustained upregulation of CD39 and CD73 in microglia 亚急性颈椎损伤后脊髓腺苷增加与小胶质细胞中CD39和CD73的持续上调有关
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-05 DOI: 10.1016/j.neuint.2025.106030
Mackenzie R. Berschel , Maria Nikodemova , Jose R. Oberto, Alexandria B. Marciante, Alysha Michaelson, Gordon S. Mitchell
Cervical spinal cord injuries (cSCI) are associated with decreased breathing ability. Although no treatment options are currently available, moderate acute intermittent hypoxia (mAIH) is a promising therapeutic modality to improve breathing function after cSCI. Moderate AIH elicits phrenic motor plasticity via distinct, competing serotonin- or adenosine-driven mechanisms that interact via powerful crosstalk inhibition that constrains or even abolishes plasticity. The dominant mechanism driving plasticity depends on the spinal serotonin/adenosine balance. Shortly after cSCI, repeated AIH exposure elicits plasticity via an adenosine-dependent mechanism but reverts to serotonin-dominance with chronic cSCI. In healthy CNS, microglia regulate AIH-induced phrenic motor plasticity via enzymatic activities of ectonucleotidases (CD39, CD73) by converting extracellular ATP to adenosine. We hypothesized that cSCI increases microglial ectonucleotidase expression, elevating adenosine levels that may alter therapeutic responses to mAIH post-cSCI. We assessed microglial CD39 and CD73 expression at the subacute (1 & 2 weeks) and chronic (8 weeks) stages post C2-hemisection, both at the injury site (C1–C3) and in spinal segments containing phrenic motor neurons below the injury (C3–C6). Both enzymes were upregulated (mRNA & protein) 1- and 2-weeks post injury but returned to baseline by 8 weeks. In association, spinal adenosine increased significantly at 2, but not 8 weeks post-injury. Further, microglial CD39 and CD73 expression strongly correlate with P2Y12 receptor expression. Thus, shifting adenosine levels between subacute and early chronic cSCI may impact mechanism regulating mAIH-induced respiratory motor plasticity and breathing recovery at different times post-cSCI.
颈脊髓损伤(cSCI)与呼吸能力下降有关。虽然目前没有治疗方案,但中度急性间歇缺氧(mAIH)是一种有希望改善cSCI后呼吸功能的治疗方式。中度AIH通过不同的、相互竞争的5 -羟色胺或腺苷驱动机制引发膈肌运动可塑性,这些机制通过强大的串扰抑制相互作用,限制甚至消除可塑性。驱动可塑性的主要机制取决于脊髓血清素/腺苷平衡。慢性脊髓损伤后不久,反复的AIH暴露通过腺苷依赖机制引起可塑性,但慢性脊髓损伤患者恢复到5 -羟色胺主导。在健康的中枢神经系统中,小胶质细胞通过胞外ATP转化为腺苷,通过胞外核苷酸酶(CD39, CD73)的酶活性调节aih诱导的膈肌运动可塑性。我们假设cSCI增加了小胶质外核苷酶的表达,提高了腺苷水平,这可能会改变cSCI后对mah的治疗反应。我们评估了亚急性(1 &;在损伤部位(C1-C3)和损伤下方包含膈运动神经元的脊髓节段(C3-C6), c2半切后2周和慢性(8周)分期。两种酶均上调(mRNA &;蛋白)损伤后1周和2周,但8周后恢复到基线。与此相关的是,脊髓腺苷在损伤后2周显著增加,而不是8周。此外,小胶质细胞CD39和CD73的表达与P2Y12受体的表达密切相关。因此,亚急性和早期慢性cSCI之间腺苷水平的变化可能影响mah诱导的cSCI后不同时间呼吸运动可塑性和呼吸恢复的调节机制。
{"title":"Increased spinal adenosine after subacute cervical injury correlates with sustained upregulation of CD39 and CD73 in microglia","authors":"Mackenzie R. Berschel ,&nbsp;Maria Nikodemova ,&nbsp;Jose R. Oberto,&nbsp;Alexandria B. Marciante,&nbsp;Alysha Michaelson,&nbsp;Gordon S. Mitchell","doi":"10.1016/j.neuint.2025.106030","DOIUrl":"10.1016/j.neuint.2025.106030","url":null,"abstract":"<div><div>Cervical spinal cord injuries (cSCI) are associated with decreased breathing ability. Although no treatment options are currently available, moderate acute intermittent hypoxia (mAIH) is a promising therapeutic modality to improve breathing function after cSCI. Moderate AIH elicits phrenic motor plasticity <em>via</em> distinct, competing serotonin- or adenosine-driven mechanisms that interact <em>via</em> powerful crosstalk inhibition that constrains or even abolishes plasticity. The dominant mechanism driving plasticity depends on the spinal serotonin/adenosine balance. Shortly after cSCI, repeated AIH exposure elicits plasticity <em>via</em> an adenosine-dependent mechanism but reverts to serotonin-dominance with chronic cSCI. In healthy CNS, microglia regulate AIH-induced phrenic motor plasticity <em>via</em> enzymatic activities of ectonucleotidases (CD39, CD73) by converting extracellular ATP to adenosine. We hypothesized that cSCI increases microglial ectonucleotidase expression, elevating adenosine levels that may alter therapeutic responses to mAIH post-cSCI. We assessed microglial CD39 and CD73 expression at the subacute (1 &amp; 2 weeks) and chronic (8 weeks) stages post C2-hemisection, both at the injury site (C1–C3) and in spinal segments containing phrenic motor neurons below the injury (C3–C6). Both enzymes were upregulated (mRNA &amp; protein) 1- and 2-weeks post injury but returned to baseline by 8 weeks. In association, spinal adenosine increased significantly at 2, but not 8 weeks post-injury. Further, microglial CD39 and CD73 expression strongly correlate with P2Y12 receptor expression. Thus, shifting adenosine levels between subacute and early chronic cSCI may impact mechanism regulating mAIH-induced respiratory motor plasticity and breathing recovery at different times post-cSCI.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"189 ","pages":"Article 106030"},"PeriodicalIF":4.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144779560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Casticin inhibits the release of synaptic vesicular glutamate from rat hippocampal nerve terminals 蓖麻素抑制大鼠海马神经末梢突触泡状谷氨酸的释放
IF 4 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-07-31 DOI: 10.1016/j.neuint.2025.106025
Cheng-Wei Lu , Tzu-Yu Lin , Wun-Jing Pan , Ya-Ying Chang , Kuan-Ming Chiu , Ming-Yi Lee , Su-Jane Wang
The effect of casticin, major polymethoxyflavone extracted from Vitex rotundifolia, on glutamate release and its underlying mechanisms was investigated in rat hippocampal synaptosomes. Casticin inhibited 4-aminopyridine (4-AP)-evoked glutamate release, with an IC50 of approximately 7.2 μM. It reduced the 4-AP-evoked increase in intrasynaptosomal Ca2+ concentration without affecting the synaptosomal membrane potential. The inhibitory effect of casticin on glutamate release was markedly prevented by ω-conotoxin GVIA, an N-type Ca2+ channel blocker, but not by ω-agatoxin VIA, a P/Q-type Ca2+ channel blocker. Further analysis of FM1-43 dye release showed that casticin suppressed glutamate release by decreasing synaptic vesicle exocytosis. Consistently, casticin also reduced 4-AP-induced phosphorylation of synapsin I, a presynaptic protein that regulates synaptic vesicle mobilization. Transmission electron microscopy (TEM) revealed that casticin decreased the proportion of release-competent synaptic vesicles in 4-AP-stimulated hippocampal synaptosomes. Taken together, these findings suggest that casticin inhibits glutamate release from rat hippocampal nerve terminals, potentially by suppression of N-type Ca2+ channel and reducing the availability of synaptic vesicles for exocytosis.
研究了黄荆主要多甲氧基黄酮酪素对大鼠海马突触体谷氨酸释放的影响及其机制。Casticin抑制4-氨基吡啶(4-AP)诱发的谷氨酸释放,IC50约为7.2 μM。它在不影响突触体膜电位的情况下降低了4- ap引起的突触体内Ca2+浓度的增加。ω-谷草毒素(ω-conotoxin, n型Ca2+通道阻滞剂)能明显抑制casticin对谷氨酸释放的抑制作用,而ω-agatoxin (ω-agatoxin, P/ q型Ca2+通道阻滞剂)则不能。对FM1-43染料释放的进一步分析表明,蓖麻素通过减少突触囊泡胞外分泌来抑制谷氨酸释放。与此一致的是,蓖麻素还降低了4- ap诱导的突触蛋白1的磷酸化,突触蛋白1是一种调节突触囊泡动员的突触前蛋白。透射电镜(TEM)显示,蓖麻素降低了4- ap刺激海马突触体中释放能力突触囊泡的比例。综上所述,这些发现表明,蓖麻素抑制大鼠海马神经末梢的谷氨酸释放,可能是通过抑制n型Ca2+通道和减少突触囊泡的可用性来实现的。
{"title":"Casticin inhibits the release of synaptic vesicular glutamate from rat hippocampal nerve terminals","authors":"Cheng-Wei Lu ,&nbsp;Tzu-Yu Lin ,&nbsp;Wun-Jing Pan ,&nbsp;Ya-Ying Chang ,&nbsp;Kuan-Ming Chiu ,&nbsp;Ming-Yi Lee ,&nbsp;Su-Jane Wang","doi":"10.1016/j.neuint.2025.106025","DOIUrl":"10.1016/j.neuint.2025.106025","url":null,"abstract":"<div><div>The effect of casticin, major polymethoxyflavone extracted from <em>Vitex rotundifolia</em>, on glutamate release and its underlying mechanisms was investigated in rat hippocampal synaptosomes. Casticin inhibited 4-aminopyridine (4-AP)-evoked glutamate release, with an IC<sub>50</sub> of approximately 7.2 μM. It reduced the 4-AP-evoked increase in intrasynaptosomal Ca<sup>2+</sup> concentration without affecting the synaptosomal membrane potential. The inhibitory effect of casticin on glutamate release was markedly prevented by ω-conotoxin GVIA, an N-type Ca<sup>2+</sup> channel blocker, but not by ω-agatoxin VIA, a P/Q-type Ca<sup>2+</sup> channel blocker. Further analysis of FM1-43 dye release showed that casticin suppressed glutamate release by decreasing synaptic vesicle exocytosis. Consistently, casticin also reduced 4-AP-induced phosphorylation of synapsin I, a presynaptic protein that regulates synaptic vesicle mobilization. Transmission electron microscopy (TEM) revealed that casticin decreased the proportion of release-competent synaptic vesicles in 4-AP-stimulated hippocampal synaptosomes. Taken together, these findings suggest that casticin inhibits glutamate release from rat hippocampal nerve terminals, potentially by suppression of N-type Ca<sup>2+</sup> channel and reducing the availability of synaptic vesicles for exocytosis.</div></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":"189 ","pages":"Article 106025"},"PeriodicalIF":4.0,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurochemistry international
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1